BOZEMAN, Mont. - eTradeWire -- Frederic Scheer, CEO and Chief Scientific Officer of Alercell, Inc., will serve as a keynote speaker at the upcoming Innovate Here Virtual Conference, hosted by the Montana Innovation Partnership (MTIP). The event will gather entrepreneurs, researchers, investors, and industry leaders to spotlight breakthrough technologies being built in Montana and beyond.

As keynote, Dr. Scheer will discuss how Alercell is transforming cancer diagnostics with its proprietary Deep Leukemic Cloud Platform (DLCP), a platform recently validated on more than 150,000 de-identified electronic medical records (EMRs) across multiple institutions. This large-scale, real-world validation demonstrated the DLCP's ability to detect leukemic transformation and stratify patient risk reliably and reproducibly across diverse patient populations.

"The Innovate Here conference is about building the future from Montana outward," said Scheer. "At Alercell, we've shown that AI-driven molecular diagnostics can be validated at scale, and now we are moving from discovery to commercial readiness. Our mission is to make leukemia detection early, accurate, and accessible."

More on eTradeWire News

• VIP Vacations Named One of Top Travel Agencies
• XP Launches Ticket Buyback Solution to Help Fans Sell Tickets Easily and Securely
• Massively parallel implementation of nonlinear functions using an optical processor
• CompliTag Simplifies the EU Digital Product Passport for SMEs: Turning Compliance from a Costly Burden to a Competitive Edge
• Natural Perfume Formulas By JoAnne Bassett For Sale

"Alercell's breakthrough work in AI-driven cancer diagnostics embodies everything Innovate Here stands for cutting-edge research, real-world validation, and the transition from discovery to market impact. Dr. Scheer's insight into scaling biotech innovation from Montana will be invaluable for our attendees. We're honored to have a leader who's proven that transformative healthcare solutions can emerge from right here in Big Sky Country," said Ann Peterson, Program Director of the Montana Innovation Partnership.

Event Highlights:

• Keynote insights from Dr. Frederic Scheer on AI, oncology, and the path to precision diagnostics.
• Breakout sessions on innovation, commercialization, and partnerships.
• Networking opportunities across tech, life sciences, and investment sectors.

The validation of Alercell's DLCP marks a significant milestone, underscoring Montana's growing role in global biotech innovation.

About Alercell, Inc.
Alercell, Inc. is a biotech company based in Bozeman, Montana, focused on developing next-generation diagnostics for oncology. Its flagship technology, the Deep Leukemic Cloud Platform (DLCP), leverages AI and real-world patient data to deliver scalable solutions for early leukemia detection and monitoring. Alercell has filed a group of patents to protect these innovations as it advances toward commercialization.  www.alercell.com

More on eTradeWire News

• Power Funding Solutions Surpasses $100 Million in Business Funding
• Kids Paint & Snack: Fall Fun Edition at The Center for Contemporary Art
• Kansas City Steak Company Shares the Return of Their Holiday Gift Box
• Shiba Delivery Hits 100 Movers — and We're Just Getting Started
• Anthony Beeler: The Educator Who Transformed Billiards Instruction

About the Montana Innovation Partnership and Innovate Here

The Montana Innovation Partnership (MTIP), based at Montana State University's TechLink Center, provides support and resources for technology-driven entrepreneurship. Innovate Here is MTIP's annual conference designed to connect innovators with funding, expertise, and community.

For more information, visit: montanainnovationpartnership.org/innovatehere.